Cell therapy demonstrates durable responses in multiple myeloma

Clinical Impact

Dec 7

Written By Frances Benson

2020

Frances Benson

Repotrectinib treatment in TKI naive patients granted FDA breakthrough therapy designation

Update on gene editing for sickle cell disease and beta-thalassemia